Citation Impact
Citing Papers
DNA Damage–Specific Control of Cell Death by Cryptochrome in p53-Mutant Ras–Transformed Cells
2012 StandoutNobel
Trabeculectomy with Simultaneous Topical Application of Mitomycin-C in Refractory Glaucoma
1990
The Mechanism of Action of Antitumor Platinum Compounds
1979
BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma
2000
Platinum(II) complexes containing iminoethers: a trans platinum antitumour agent
1995
Binding Characteristics of (–)‐(R)‐2‐Aminomethylpyrrolidine(1,1‐cyclobutanedi‐carboxylato)‐2‐platinum(II) to DNA, RNA and Protein Molecules in HeLa Cells and Its Lethal Effect: Comparison with cis‐ and trans‐Diammmedichloroplatinums(II)
1994
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
2013 StandoutNature
Synthesis, characterization, and study on HeLa cells activity of a dinuclear complex [Cu4(phen)4(H2O)2]·(pyri)·3H2O
2011
Crystal structure of parallel quadruplexes from human telomeric DNA
2002 StandoutNature
Contrasting cellular uptake pathways for chlorido and iodido iminopyridine ruthenium arene anticancer complexes
2012
Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I
1996
Phase I and pharmacokinetic study of an oral platinum complex given daily for 5 days in patients with cancer.
1997
Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality
1990 StandoutNobel
Carboplatin as opposed to cisplatin does not stimulate the expression of the human immunodeficiency virus long terminal repeat sequences
1992
The resurgence of platinum-based cancer chemotherapy
2007 Standout
In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473
1998
The Pathophysiology and Treatment of Hereditary Tyrosinemia Type 1
2001
Ligand-induced distortion of an active site in thymidylate synthase upon binding anticancerdrug 1843U89
1995
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
New Cisplatin Analogues in Development
1993
Nonclassical Platinum Antitumor Agents: Perspectives for Design and Development of New Drugs Complementary to Cisplatin
1993
Primary open-angle glaucoma
2004 Standout
Apoptosis Induction and DNA Interstrand Cross-Link Formation by Cytotoxictrans-[PtCl2(NH(CH3)2)(NHCH(CH3)2)]: Cross-Linking between d(G) and Complementary d(C) within Oligonucleotide Duplexes
2002
Intracellular metabolism of the orally active platinum drug JM216: influence of glutathione levels
1996
On the antitumor properties of novel cyclometalated benzimidazole Ru(ii), Ir(iii) and Rh(iii) complexes
2013
UCSF Chimera—A visualization system for exploratory research and analysis
2004 Standout
Preclinical Perspectives on Platinum Resistance
2000
Cycloplatam: A novel platinum compound exhibiting a different spectrum of anti-tumour activity to cisplatin
1995
Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells
2005
Oral chemotherapy: rationale and future directions.
1998
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
2008 Standout
Three generations of α,γ-diaminobutyric acid modified poly(propyleneimine) dendrimers and their cisplatin-type platinum complexes
2006
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum–iminoether complexes with different configuration at the iminoether ligands
1999
Interactions with Aromatic Rings in Chemical and Biological Recognition
2003 Standout
Tumour-inhibiting platinum complexes—state of the art and future perspectives
2003
A G-Quadruplex-Interactive Potent Small-Molecule Inhibitor of Telomerase Exhibiting in Vitro and in Vivo Antitumor Activity
2002
Induced pluripotent stem cell–derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice
2010 StandoutNobel
In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin
1993
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Recognition and management of complex sleep-disordered breathing
2005
Pairwise specificity and sequential binding in enzyme catalysis: thymidylate synthase
1990
Structure and function of “metalloantibiotics”
2003
New platinum antitumor complexes
1993
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
New Developments and Approaches in the Platinum Arena
2000
In Situ Click Chemistry: Enzyme‐Generated Inhibitors of Carbonic Anhydrase II
2004 StandoutNobel
DNA‐binding properties of novel cis‐ and trans platinum‐based anticancer agents in 2 human ovarian carcinoma cell lines
1995
Effect of p53 Status on Sensitivity to Platinum Complexes in a Human Ovarian Cancer Cell Line
2000
Current status of the development of trans-platinum antitumor drugs
2000
Platinum complex-DNA interactions and anticancer activity
1978
Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems.
1991
Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-((2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino)benzoyl)-l-glutamic acid (CB3717), on human lymphoblastoid cells
1983
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
Bioorganometallic Chemistry of Ferrocene
2004 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Challenges for Metals in Medicine: How Nanotechnology May Help To Shape the Future
2013
Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors.
1990
Metalle in der Medizin
1999
Calculating Structures and Free Energies of Complex Molecules: Combining Molecular Mechanics and Continuum Models
2000 Standout
Action mechanism of ABC excision nuclease on a DNA substrate containing a psoralen crosslink at a defined position.
1986 StandoutNobel
High-performance liquid chromatographic separation of platinum complexes containing the cis-1,2-diaminocyclohexane carrier ligand
1986 StandoutNobel
In Situ Click Chemistry: Enzyme Inhibitors Made to Their Own Specifications
2004 StandoutNobel
Insights into Mechanisms of Cisplatin Resistance and Potential for Its Clinical Reversal
1996
Chemical Glycobiology
2001 StandoutScienceNobel
Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cells.
1991 StandoutNobel
Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure–Activity Relationship Study
2015
The coordination chemistry of platinum anticancer drugs and related compounds with DNA
1990
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy
2004 Standout
The nature of cis amine Pd(II) and antitumor cis amine Pt(II) complexes in aqueous solutions
1976
Current status of trans-platinum compounds in cancer therapy
2001
Platinum(IV) antitumour compounds: their bioinorganic chemistry
2002
Additions to Metal-Activated Organonitriles
2002 Standout
Asymmetric Catalysis by Architectural and Functional Molecular Engineering: Practical Chemo- and Stereoselective Hydrogenation of Ketones
2001 StandoutNobel
Dynamic Combinatorial Chemistry
2006 Standout
Theoretical Studies Suggest a New Antifolate as a More Potent Inhibitor of Thymidylate Synthase
2000
Diazaquinomycin A, a new antifolate antibiotic, inhibits thymidylate synthase.
1985 StandoutNobel
Iterative in Situ Click Chemistry Assembles a Branched Capture Agent and Allosteric Inhibitor for Akt1
2011 StandoutNobel
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
Reprogramming homing endonuclease specificity through computational design and directed evolution
2013 StandoutNobel
Physical studies on the binding of cis-dichlorodiamine platinum(II) to DNA and homopolynucleotides
1975
METABOLIC SUBSTRATE ENGINEERING AS A TOOL FOR GLYCOBIOLOGY
2002 StandoutNobel
Insertion of an intracisternal A particle within the 5'-regulatory region of a gene encoding folate-binding protein in L1210 leukemia cells in response to low folate selection. Association with increased protein expression.
1992 StandoutNobel
Why Does Cisplatin Reach Guanine-N7 with Competing S-Donor Ligands Available in the Cell?
1999
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Structure-Based Strategies for Drug Design and Discovery
1992 Science
Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
2014
Interactions between mammalian cell DNA and inorganic platinum compounds—I
1974
A new folate antimetabolite, 5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis
1989
Liver Regeneration
1997 StandoutScience
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Complementary roles of gasotransmitters CO and H2S in sleep apnea
2017 StandoutNobel
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
In Situ Selection of Lead Compounds by Click Chemistry: Target-Guided Optimization of Acetylcholinesterase Inhibitors
2005 StandoutNobel
Site-directed ligand discovery
2000
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and health equity in the adult population
2021
Chemical reactivity of monofunctional platinum-DNA adducts
1986
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Thiourea Reverses Cross-Links and Restores Biological Activity in DNA Treated with Dichlorodiaminoplatinum(II)
1979 StandoutScienceNobel
Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase
2010 StandoutNobel
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and-resistant human ovarian carcinoma cell lines by amphotericin B
1994
The influence of structure on the activity and toxicity of Pt anti-cancer drugs
1997
Structure-based drug design (SBDD): Every structure tells a story...
1993
The current status of new platinum analogs.
1992
Works of Mark Jones being referenced
A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
1994
Acquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenografts
1993
The establishment, characterization and calibration of human ovarian carcinoma xenografts for the evaluation of novel platinum anticancer drugs
1990
Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1
1990
Effect of CO<sub>2</sub> Inhalation on Central Sleep Apnea and Arousals from Sleep
2004
A Targeted and Tailored eHealth Weight Loss Program for Young Women: The Be Positive Be Healthe Randomized Controlled Trial
2018
Delivery of Antifibroblast Agents as Adjuncts to Filtration Surgery - Part II: Delivery of 5-Fluorouracil and Bleomycin in a Collagen Implant: Pilot Study in the Rabbit
1986
Selection of potential second generation platinum compounds
1978
Schedule dependency of orally administered bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) in vivo.
1994
New platinum complexes with anti-tumour activity
1972
cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
1997
Some in vivo and in vitro antitumour effects of the deoxyfluoro-d-glucopyranoses
1973
A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in mice
1981
Structure and activity relationships of platinum complexes with anti-tumour activity
1975